echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In August 2017, 26 pharmaceutical companies were successfully listed

    In August 2017, 26 pharmaceutical companies were successfully listed

    • Last Update: 2017-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] on September 5, according to the statistics of local medical stations, in August 2017, a total of 26 pharmaceutical enterprises were successfully listed Among them, there are 22 new third boards, including Tianyi pharmaceutical, Aimin pharmaceutical, Batong biology, etc Among them, Zhaoyan new medicine and Shengda biology are listed on the Shanghai Stock Exchange; Haite biology and Eide biology are listed on the growth enterprise market of Shenzhen Stock Exchange; the other 22 are listed on the new third board, including Tianyi pharmaceutical, Aimin pharmaceutical, Batong biology, etc In terms of the distribution area, there are 5 enterprises in Hubei Province, including Haite biology, Aimin pharmaceutical, Beishen pharmaceutical, aolvxin and Shuangxing pharmaceutical, followed by 3 enterprises in Beijing and Zhejiang It is understood that Wuhan Haite biopharmaceutical Co., Ltd was founded on April 8, 1992 Its main business is the research, development, production and sales of biological products (injection of mouse nerve growth factor freeze-dried powder injection, injection of anti HBV transfer factor freeze-dried powder injection), thrombin and other chemicals In the first half of 2017, the company's revenue was 389 million yuan, a year-on-year increase of 16.92%; its net profit was 0.69, a year-on-year increase of 13.12% As of September 5, the total market value of the company was 6.55 billion yuan Xiamen Eide Biomedical Technology Co., Ltd was founded on February 21, 2008 It is engaged in the development, production and related technical services of molecular diagnosis and immunodiagnosis reagents (three types of 6840 in vitro diagnostic reagents) and the production and sales of class I medical devices and scientific research experimental instruments In the first half of 2017, the company achieved an operating revenue of 149 million yuan, an increase of 30.50% year on year; its net profit was 44.0748 million yuan, an increase of 31.6824% year on year As of September 5, the total market value was 6.819 billion Founded on August 11, 1995, Beijing Zhaoyan New Drug Research Center Co., Ltd is a national "12th Five year major new drug creation" platform and Beijing Key Laboratory for drug safety evaluation In the first half of 2017, the revenue was RMB 95.02 million and the attributable net profit was RMB 12.18 million As of September 5, the total market value reached 2.871 billion Zhejiang Shengda biopharmaceutical Co., Ltd was founded on February 8, 1999 It mainly produces vitamin series products, pharmaceutical APIs and intermediates In 2017, the revenue was 251 million yuan and the net profit was 41.64 million yuan As of September 5, the total market value reached 4.098 billion yuan In recent years, the new third board is a popular way of listing for small and medium-sized enterprises Some insiders said that the new three board market filled the vacuum between listed and unlisted, and made China's capital market more perfect According to statistics, there are 11557 enterprises listed on the new third board Original title: in August, 26 pharmaceutical enterprises listed on the new third board accounted for 22 enterprises to seize the opportunity of pharmaceutical machinery and equipment industry Please download app (Pharma, Android version)!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.